The nation of Zimbabwe has turned down a substantial US health deal worth 367 million US dollars (£272m) over five years over the United States' insistence on sensitive data.
This rejection became public after a government memo from December was disclosed, indicating that President Emmerson Mnangagwa deemed the deal was "lopsided".
An official representative has since stated that the United States was seeking health data for research and commercial gain but refused to share the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate process of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for further talks to reach a deal agreeable to all parties so the country's critical HIV treatment initiative can continue.
Wider Background
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a court suspended a related deal with the US following legal challenges were raised about the safety of Kenyans' medical information.
Since resuming office last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump claimed its spending was "wasteful" and his government was seeking government-to-government deals to enhance openness and accountability.
Based on statements, 16 African countries have to date agreed to similar agreements, constituting over $18.3bn in new funding.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration might have yielded extraordinary benefits for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy through American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, without any corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that provided information," he stated.
"In essence, our country would provide the raw materials for medical research without any assurance that the resulting innovations would be accessible to our population should a future disease outbreak emerge."
National Interest and Global Health
He also pointed out that the American exit from the global health body and its pursuit of bilateral deals were undermining frameworks already established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This framework is designed to guarantee that when a nation contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage continued dialogue with our US partners on how subsequent co-operation could be arranged in a manner that respects the independence and dignity of both nations."
Health Experts Response
A leading public health body stated it understood the government's concerns, but recommended that talks must proceed given that a large portion of the nation's Aids initiatives depended on external financing.
"Where specific concerns arise, including those relating to data governance or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group said.
This impasse emphasises the continuing challenges between receiving vital international aid and safeguarding national sovereignty in an increasingly interconnected world.